Search Results - V. D. Mosyagin

Authorisation of Non-Innovator Biotherapeutic (Biosimilar) Products in the USA by A. A. Soldatov, Zh. I. Avdeeva, V. P. Bondarev, V. D. Mosyagin

Get full text

Factor VIII products: key aspects of development, clinical research and use (part 1) by Zh. I. Avdeeva, A. A. Soldatov, V. P. Bondarev, V. D. Mosyagin, V. A. Merkulov

Get full text

Factor VIII products: key aspects of development, clinical research and use (part 2) by Zh. I. Avdeeva, A. A. Soldatov, V. P. Bondarev, V. D. Mosyagin, V. A. Merkulov

Get full text

METHODOLOGICAL APPROACHES TO EXPERT EVALUATION OF PRECLINICAL AND CLINICAL TRIALS OF HUMAN IMMUNOGLOBULIN PRODUCTS by V. B. Ivanov, V. D. Mosyagin, E. Yu. Kudasheva, Yu. V. Olefir, V. A. Merkulov, I. V. Borisevitch, V. P. Bondarev

Get full text

Russian and International Regulatory Recommendations for the Development and Marketing Authorisation of COVID-19 Vaccines in the Context of the Pandemic by A. A. Soldatov, Zh. I. Avdeeva, V. P. Bondarev, V. A. Merkulov, V. D. Mosyagin, V. B. Ivanov, D. V. Gorenkov, L. M. Khantimirova

Get full text

First available biosimilar monoclonal antibodies by Zh. I. Avdeeva, A. A. Soldatov, N. A. Alpatova, V. P. Bondarev, Yu. V. Olefir, V. A. Merkulov, V. D. Mosyagin, N. V. Medunitsyn

Get full text

Recombinant granulocyte colony stimulating factor biosimilars. Quality assessment by Zh. I. Avdeeva, A. A. Soldatov, N. A. Alpatova, M. V. Kiselevsky, S. L. Lysikova, V. P. Bondarev, N. V. Medunitsyn, V. D. Mosyagin, V. A. Merkulov, A. N. Mironov

Get full text